Angion Biomedica expands staff with new Director of Chemistry and Director of Clinical Operations

Our therapeutic programs modulate the natural protective, reparative and regenerative pathways of the body in both orphan diseases and larger clinical indications.

Our robust pre-clinical and clinical portfolio targets areas of high unmet medical need across a spectrum of therapeutic indications, including acute kidney injury (AKI) and chronic kidney disease (CKD).